AI English summary of an SEC filing — figures as filed
The company said its board elected Jon Moeller as a new director on November 19, 2024, effective December 1, 2024. It described Moeller as Chairman of the Board, President and Chief Executive Officer of Procter & Gamble.
Key points
AI summaryThe company said its board elected Jon Moeller as a new director on November 19, 2024, effective December 1, 2024. It described Moeller as Chairman of the Board, President and Chief Executive Officer of Procter & Gamble.
Lilly said Moeller will serve on the Audit Committee and the Directors and Corporate Governance Committee and will stand for election by shareholders at the annual meeting in May 2026. The board determined that Moeller is independent under New York Stock Exchange standards and the company's director independence guidelines.
Eli Lilly said Karen Walker notified the board of her resignation on November 19, 2024, effective December 31, 2024. The company said her decision to resign did not stem from any disagreement with the company over its operations, policies or practices.
The company said Walker has served on the board since 2018, including as a member of the Audit and Talent and Compensation Committees. It said Walker is expected to collaborate with the company on certain digital commercial activities starting in 2025.
Summary
AI-writtenAnalysis scope · Filing body and confirmed press-release exhibitWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.
Jon Moeller joins board, effective December 1, 2024
The company said its board elected Jon Moeller as a new director on November 19, 2024, effective December 1, 2024. It described Moeller as Chairman of the Board, President and Chief Executive Officer of Procter & Gamble.
Source · Based on the filing body and exhibits
Moeller's committee roles and independence determination
Lilly said Moeller will serve on the Audit Committee and the Directors and Corporate Governance Committee and will stand for election by shareholders at the annual meeting in May 2026. The board determined that Moeller is independent under New York Stock Exchange standards and the company's director independence guidelines.
Source · Based on the filing body and exhibits
Karen Walker resigns from board, effective December 31, 2024
Eli Lilly said Karen Walker notified the board of her resignation on November 19, 2024, effective December 31, 2024. The company said her decision to resign did not stem from any disagreement with the company over its operations, policies or practices.
Source · Based on the filing body and exhibits
Walker's board service since 2018 and collaboration from 2025
The company said Walker has served on the board since 2018, including as a member of the Audit and Talent and Compensation Committees. It said Walker is expected to collaborate with the company on certain digital commercial activities starting in 2025.
Source · Based on the filing body and exhibits
AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.
Original filing
The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.
Loading the filing text…